Global Coenzyme Q10 (Ubiquinone) Market Growth 2019-2024

SKU ID : LPI-13842870 | Publishing Date : 08-Feb-2019 | No. of pages : 132

Ubiquinone market, Coenzyme Q10, also known as ubiquinone, ubidecarenone, coenzyme Q, and abbreviated at times to CoQ10, is a naturally-occurring compound located in every cell in the body. Coenzyme Q10, or merely CoQ10, plays a key role in producing energy in the mitochondria, the part of a cell responsible for the production of energy in the form of ATP. Coenzyme Q10, in some cases referred to merely as CoQ10, is synthesized inside our bodies, it is also known to be found in meats, particularly in the heart, such as pork, chicken and beef, and many oils.
The global sales of coenzyme Q10 increased from 823 tons in 2013 to 1302 tons in 2017, at a CAGR of 12.15%. In 2017, the global coenzyme Q10 market is led by China. Japan is the second-largest region-wise market.

As Chinese overall economic downward trend in the past few years, and international conomic situation is complicated, in the next few years there will be many uncertainties, and coupled with Coenzyme Q10 industry in short supply on the market in the past few years, more and more companies enter into Coenzyme Q10 industry, the current demand for Coenzyme Q10 product is relatively high, but lightly supply exceeds demand. Ordinary Coenzyme Q10 products on the China market do not sell well; Coenzyme Q10’s price is lower than past years.

Currently, Kingdomway, Kaneka, ZMC and Space Biologyare the leaders of coenzyme Q10 industry. Kingdomway is a global leader. In 2017, the production of Kingdomway was 386 MT, and the company holds a share of 29.65%. In Europe and the United States, Kingdomway and Kaneka are the market leader. The product demand is rising in China, but it is slow. In the United States, the demand is rising fast. The demand for health products drives the development of this industry. At present, there are dozens of companies in the United States who are coenzyme Q10 supplement manufacturers and are still growing.

Coenzyme Q10 is mainly used for food, medicine and cosmetics. In 2017, food application holds 76% of the consumption market share.

Although sales of Coenzyme Q10 brought a lot of opportunities, the study group recommends the new entrants just having money but without technical advantage and downstream support do not to enter into the Coenzyme Q10 field.


According to this study, over the next five years the Coenzyme Q10 (Ubiquinone) market will register a 5.1% CAGR in terms of revenue, the global market size will reach US$ 490 million by 2024, from US$ 370 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Coenzyme Q10 (Ubiquinone) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Coenzyme Q10 (Ubiquinone) market by product type, application, key manufacturers and key regions and countries.

This study considers the Coenzyme Q10 (Ubiquinone) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Chemical Synthesis
Microbial Fermentation
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Food
Medicine
Cosmetics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Kingdomway
Kaneka
ZMC
Space Biology
NHU
Pharma Essentia
Yuxi Jiankun
Haotian

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Coenzyme Q10 (Ubiquinone) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Coenzyme Q10 (Ubiquinone) market by identifying its various subsegments.
Focuses on the key global Coenzyme Q10 (Ubiquinone) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Coenzyme Q10 (Ubiquinone) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Coenzyme Q10 (Ubiquinone) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
3660
7320

5490


  • market Reports market Reports